Table 2. Presence of collateral symptoms in both current and former users, as well as their disappearance after the end of the cycle.
| Variables | Total n (%) | Former Users n (%) |
Current Users n (%) |
P |
|---|---|---|---|---|
| Collateral Symptoms | ||||
| Yes | 643 (89,4%) | 466a (88,8%) | 177a (91,2%) | 0,338 |
| No | 76 (10,6%) | 59a (11,2%) | 17a (8,8%) | |
| Symptoms | ||||
| Increased Libido | 327 (45,5%) | 213a (40,6%) | 114b (58,8%) | 0,0001 |
| Acne | 308 (42,8%) | 213a (40,6%) | 95b (49,0%) | 0,043 |
| Irritability / Aggressiveness | 233 (32,4%) | 157a (29,9%) | 76b (39,2%) | 0,018 |
| Headache | 159 (22,1%) | 119a (22,7%) | 40a (20,6%) | 0,557 |
| Decreased Libido | 111 (15,4%) | 77a (14,7%) | 34a (17,5%) | 0,346 |
| Gynecomastia | 97 (13,5%) | 63a (12,0%) | 34a (17,5%) | 0,054 |
| Hypertension | 91 (12,7%) | 55a (10,5%) | 36b (18,6%) | 0,004 |
| Change in Menstrual Cycle | 73 (10,2%) | 58a (11,0%) | 15a (7,7%) | 0,191 |
| Deepening of the Voice | 71 (9,9%) | 50a (9,5%) | 21a (10,8%) | 0,604 |
| Depression | 50 (7,0%) | 26a (5,0%) | 24b (12,4%) | 0,001 |
| Dependency | 31 (4,3%) | 16a (3,0%) | 15b (7,7%) | 0,006 |
| Vomiting / Nausea | 25 (3,5%) | 17a (3,2%) | 8a (4,1%) | 0,545 |
| Other | 59 (8,2%) | 48a (9,1%) | 11a (5,7%) | 0,132 |
| Symptoms Disappeared After Cycle | ||||
| Yes | 555 (77,2%) | 415a (79,0%) | 140a (72,2%) | 0,025 |
| No | 98 (13,6%) | 71a (13,5%) | 27a (13,9%) | |
| Some | 66 (9,2%) | 39a (7,4%) | 27b (13,9%) |
Proportion z test. The different letters in the lines indicate significant differences (p <0.05).